P.J., M.A. Camps‐Palau, J.A. Mcknight, et al. 2004. Phase I & IB trials of murine tyrosinase ± human GM‐Csf Dna vaccination in dogs with advanced malignant melanoma. Vet Cancer Soc Proc 24:55.52 Bergman, P.J., M.A. Camps‐Palau, J.A. Mcknight, et al. 2006. Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center. Vaccine 24:4582–4585.
53 Bergman, P.J., M.S. Kent, and J.P. Farese. 2013. 19 – Melanoma. In Withrow and MacEwen's Small Animal Clinical Oncology, 5th edition. R.L. Page, S.J. Withrow, and D.M. Vail, editors. St. Louis: W.B. Saunders.
54 Bergman, P.J., E.G. Macewen, I.D. Kurzman, et al. 1996. Amputation and carboplatin for treatment of dogs with osteosarcoma: 48 cases (1991–1993). J Vet Intern Med 10:76–81.
55 Bergman, P.J., J. Mcknight, A. Novosad, et al. 2003b. Long‐term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: A phase I trial. Clin Cancer Res 9:1284–1290.
56 Bergman, P.J., S.J. Withrow, R.C. Straw, et al. 1994. Infiltrative lipoma in dogs: 16 cases (1981–1992). J Am Vet Med Assoc 205:322–324.
57 Berlato, D., D. Schrempp, N. Van Den Steen, et al. 2012. Radiotherapy in the management of localized mucocutaneous oral lymphoma in dogs: 14 cases. Vet Comp Oncol 10:16–23.
58 Bertelli, G., A. Gozza, G.B. Forno, et al. 1995. Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: A prospective clinical study. J Clin Oncol 13:2851–2855.
59 Betz, D., D. Schoenrock, R. Mischke, et al. 2012. Postoperative treatment outcome in canine mammary tumors. Multivariate analysis of the prognostic value of pre‐ and postoperatively available information. Tierarztl Prax Ausg K Kleintiere Heimtiere 40:235–242.
60 Bianco, S.R., J. Sun, S.P. Fosmire, et al. 2003. Enhancing antimelanoma immune responses through apoptosis. Cancer Gene Ther 10:726–736.
61 Biller, B. 2014. Metronomic chemotherapy in veterinary patients with cancer: Rethinking the targets and strategies of chemotherapy. Vet Clin North Am Small Anim Pract 44:817–829.
62 Birchard, S.J. 2006. Thyroidectomy in the cat. Clin Tech Small Anim Pract 21:29–33.
63 Blackburn, A.L., A.C. Berent, C.W. Weisse, et al. 2013. Evaluation of outcome following urethral stent placement for the treatment of obstructive carcinoma of the urethra in dogs: 42 cases (2004–2008). J Am Vet Med Assoc 242:59–68.
64 Blackwood, L. and J.M. Dobson. 1996. Radiotherapy of oral malignant melanomas in dogs. J Am Vet Med Assoc 209:98–102.
65 Bland, K.I., W.E. Palin, J.A. Von Fraunhofer, et al. 1984. Experimental and clinical observations of the effects of cytotoxic chemotherapeutic drugs on wound healing. Ann Surg 199:782–790.
66 Bleakley, S., C.G. Duncan, and E. Monnet. 2015. Thoracoscopic lung lobectomy for primary lung tumors in 13 dogs. Vet Surg 44:1029–1035.
67 Bolon, B., M.B. Calderwood Mays, and B.J. Hall. 1990. Characteristics of canine melanomas and comparison of histology and DNA ploidy to their biologic behavior. Vet Pathol 27:96–102.
68 Bommarito, D.A., M.S. Kent, K.A. Selting, et al. 2011. Reirradiation of recurrent canine nasal tumors. Vet Radiol Ultrasound 52:207–212.
69 Bommer, N.X., A.M. Hayes, T.J. Scase, et al. 2012. Clinical features, survival times and Cox‐1 and Cox‐2 expression in cats with transitional cell carcinoma of the urinary bladder treated with meloxicam. J Feline Med Surg 14:527–533.
70 Boretti, F.S., N.S. Sieber‐Ruckstuhl, S. Schafer, et al. 2013. Duration of t4 suppression in hyperthyroid cats treated once and twice daily with transdermal methimazole. J Vet Intern Med 27:377–381.
71 Boretti, F.S., N.S. Sieber‐Ruckstuhl, S. Schafer, et al. 2014. Transdermal application of methimazole in hyperthyroid cats: A long‐term follow‐up study. J Feline Med Surg 16:453–459.
72 Boria, P.A., N.W. Glickman, B.R. Schmidt, et al. 2005. Carboplatin and piroxicam therapy in 31 dogs with transitional cell carcinoma of the urinary bladder. Vet Comp Oncol 3:73–80.
73 Boria, P.A., D.J. Murry, P.F. Bennett, et al. 2004. Evaluation of cisplatin combined with piroxicam for the treatment of oral malignant melanoma and oral squamous cell carcinoma in dogs. J Am Vet Med Assoc 224:388–394.
74 Borrego, J.F., J.C. Cartagena, and J. Engel. 2009. Treatment of feline mammary tumours using chemotherapy, surgery and a Cox‐2 inhibitor drug (meloxicam): A retrospective study of 23 cases (2002–2007) . Vet Comp Oncol 7:213–221.
75 Bostock, D.E. and M.T. Dye. 1980. Prognosis after surgical excision of canine fibrous connective tissue sarcomas. Vet Pathol 17:581–588.
76 Boston, S.E., M. Barry, M.L. and O’Sullivan. 2011. Transtumoral plating as a novel method for palliative limb spare and thromboembolism in a dog with a distal radial primary bone tumor. Can Vet J 52:650–655.
77 Boston, S.E., F. Duerr, N. Bacon, et al. 2007. Intraoperative radiation for limb sparing of the distal aspect of the radius without transcarpal plating in five dogs. Vet Surg 36:314–323.
78 Boston, S.E., X. Lu, W.T. Culp, et al. 2014. Efficacy of systemic adjuvant therapies administered to dogs after excision of oral malignant melanomas: 151 cases (2001–2012). J Am Vet Med Assoc 245:401–407.
79 Boston, S. and A. Singh. 2014. Total cystectomy for treatment of transitional cell carcinoma of the urethra and bladder trigone in a dog. Vet Surg 43:294–300.
80 Boston, S.E. and O.T. Skinner. 2018. Limb shortening as a strategy for limb sparing treatment of appendicular osteosarcoma of the distal radius in a dog. Vet Surg 47:136–145.
81 Boston, S.E., A. Vinayak, X. Lu, et al. 2017. Outcome and complications in dogs with appendicular primary bone tumors treated with stereotactic radiotherapy and concurrent surgical stabilization. Vet Surg 46:829–837.
82 Bowles, K., D. Desandre‐Robinson, L. Kubicek, et al. 2016. Outcome of definitive fractionated radiation followed by exenteration of the nasal cavity in dogs with sinonasal neoplasia: 16 cases. Vet Comp Oncol. 14(4):350–360.
83 Boyce, K.L. and B.E. Kitchell. 2000. Treatment of canine lymphoma with Copla/Lvp. J Am Anim Hosp Assoc 36:395–403.
84 Bracha, S., R. Walshaw, T. Danton, et al. 2014. Evaluation of toxicities from combined metronomic and maximal‐tolerated dose chemotherapy in dogs with osteosarcoma. J Small Anim Pract 55:369–374.
85 Bradley, R.L., E.G. Macewen, and A.S. Loar. 1984. Mandibular resection for removal of oral tumors in 30 dogs and 6 cats. J Am Vet Med Assoc 184:460–463.
86 Bray, J.P., G.A. Polton, K.D. Mcsporran, et al. 2014a. Canine soft tissue sarcoma managed in first opinion practice: Outcome in 350 cases. Vet Surg 43:774–782.
87 Bray, J.P., D.R. Worley, R.A. Henderson, et al. 2014b. Hemipelvectomy: Outcome in 84 dogs and 16 cats. A veterinary society of surgical oncology retrospective study. Vet Surg 43:27–37.
88 Brearley, M.J., A.M. Hayes, and S. Murphy. 1999. Hypofractionated radiation therapy for invasive thyroid carcinoma in dogs: A retrospective analysis of survival. J Small Anim Pract 40:206–210.
89 Bregazzi, V.S., S.M. Larue, E. McNiel, et al. 2001. Treatment with a combination of doxorubicin, surgery, and radiation versus surgery
